Focus Partners Wealth’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.93M Sell
116,987
-94,994
-45% -$7.66M 0.01% 722
2026
Q1
$15M Buy
211,981
+7,412
+4% +$555K 0.02% 586
2025
Q4
$16.1M Buy
204,569
+138,484
+210% +$11M 0.02% 544
2025
Q3
$5.44M Buy
66,085
+24,158
+58% +$1.9M 0.01% 722
2025
Q2
$3.37M Sell
41,927
-847
-2% -$65.4K 0.01% 784
2025
Q1
$3.43M Buy
42,774
+231
+0.5% +$19.2K 0.01% 732
2024
Q4
$3.48M Buy
42,543
+4,834
+13% +$402K 0.01% 709
2024
Q3
$3.11M Buy
37,709
+8,076
+27% +$603K 0.01% 674
2024
Q2
$2.08M Buy
29,633
+3,105
+12% +$222K 0.01% 646
2024
Q1
$1.97M Buy
26,528
+6,127
+30% +$427K 0.02% 486
2023
Q4
$1.35M Buy
+20,401
New +$1.28M 0.02% 404

Other funds holding MET

Focus Partners Wealth's MET Position: Q2 2026 in Review

Focus Partners Wealth reduced its MetLife (MET) stake by 45% in Q2 2026, selling an estimated $7.66M and leaving 116,987 shares worth $9.93M. The position accounts for 0.01% of the portfolio, ranked #722.

Focus Partners Wealth first reported a position in MET in Q4 2023 and has held it in 11 quarters since. The position peaked at $16.1M in Q4 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Focus Partners Wealth held 116,987 shares of MetLife worth $9.93M as of Q2 2026.
  • Focus Partners Wealth sold 94,994 MetLife shares in Q2 2026, an estimated $7.66M.
  • MetLife made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #722 holding.
  • Focus Partners Wealth first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's MetLife position peaked at $16.1M in Q4 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.